Please activate JavaScript!
Please install Adobe Flash Player, click here for download

today EAO Paris Sep. 30 & Oct. 1, 2016

business 25th EAO Annual Scientific Meeting 26  Over 15 years ago Nobel Biocare began producing its original Multi- unit Abutment, which was a first for the industry at the time. Since then, this product has had a big impact on patient treatment as it started the trend for restoring multiple teeth us- ing tilted implant placement which is now backed by a wealth of clinical evidence. A decade and a half since the launch of Nobel Biocare’s original Multi-unit Abutment, the concept has further evolved with the intro- duction of the Multi-unit Abutment Plus. Since the launch of the origi- nal version, Nobel Biocare’s Multi- unit Abutment has established itself as a key stone of the clinically and scientifically proven All-on-4 treat- ment concept. It makes it possible to restore a full arch with a fixed resto- ration using just four implants and so has allowed hundreds of thou- sands of edentulous and soon-to-be edentulous patients to benefit from a minimally invasive treatment pro- cess. Similar to its predecessor, the Multi-unit Abutment Plus allows for the tilting of the two posterior im- plants, meaning longer implants can be positioned in the anterior bone, rather than in the posterior where the bone is often resorbed. This in- creases bone-to-implant contact and reduces the need for vertical bone augmentation. Tilting the implants also reduces cantilevers, improving support for the prostheses. Further- more, tilting the implants helps avoid critical nerve structures and the maxillary sinus. All this makes for a less invasive and more efficient procedure. Added efficiency now comes from the innovative snap-fit function of the Multi-unit Abutment Plus. The Multi-unit Abutment Plus is de- signed to substantially reduce the chair time required to perform a den- ture conversion, a procedure com- monly used for the All-on-4 treat- ment concept. By introducing a snap- fit function between the Temporary Snap Coping Multi-unit Plus and the abutment, screws are no longer re- quired during the try-in process. This means the practice of removing the temporary cylinders and the den- ture several times during the conver- sion process can be done in a few snaps, with no need to tighten and loosen four screws each time. This represents a significant time-saving opportunity for the clinician. It can also dramatically increase patient comfort and eliminates any worry about the screws potentially drop- ping out. An immediate solution for edentulism Nobel Biocare implants are de- signed to offer primary stability at a level that allows for the restora- tion to be placed immediately. The TiUnitesurfaceandpatentedgrooves then help maintain this stability dur- ing osseointegration. In combination with Nobel Biocare’s Multi-unit Abut- ment Plus and the All-on-4 treatment concept, this allows many edentu- lous and soon-to-be edentulous pa- tients to leave the dental surgery with a full set of teeth and renewed self-confidence. Nobel Biocare’s phi- losophy is that patients should live every day to the fullest, and that the months of waiting for teeth in de- layed loading protocols should be avoided if the clinical parameters al- low. Nobel Biocare’s Multi-unit Abut- ments open the door to a complete individualiSed restorative portfolio through NobelProcera. A wide range of precision-milled and Aesthetically excellent restorative frameworks in both titanium and zirconia are avail- able. Though only a small part of Nobel Biocare’s All-on-4 treatment concept, the Multi-unit Abutment plays a very substantial role. With- out it, this innovative and effective solution for edentulous and soon- to-be edentulous patients would not be possible. The new Multi-unit Abutment Plus offers the same ben- efits together with a more efficient workflow. It is the supporting act that allows the All-on-4 treatment concept to SHINE, both for patients and clinicians.  Nobel Biocare Switzerland nobelbiocare.com/mua Booth D2 NOBEL BIOCARE’S MULTI-UNIT ABUTMENT PLUS  The global leader in implant sta- bility measurement, Osstell, just announced its partnership with the Austrian dental company W&H Dentalwerk . The collab- oration will focus on bring- ing innovative all-in-one solu- tions to support dental im- plant clinicians in their every- day practice. The first result of this partnership is now be- ing introduced in the form of W&H’s latest generation surgi- cal device, Implantmed, for which an integrated Osstell ISQ module is available. This unique combination of tech- nologies allows a new stand- ard to be set in the global den- tal industry, helping clinicians im- prove patient confidence and com- fort and giving users significant benefits in terms of functional- ity and optimum efficiency during treatment. W&H is known in the global dental market as a leading manufacturer of den- tal precision instruments and devices. Innovative prowess and outstanding quality have been at the heart of the company for over 125 years, as have lasting collaborative partnerships. “We are very happy that such a recog- nised company like W&H has cho- sen to partner with Osstell, with the intent to bring innovative products to the market that will help clinicians to even further improve implant treatment and patient comfort. Osstell’s implant sta- bility diagnostics combined with the state of the art Implantmed for the surgical placement, provides a unique opportunity benefitting both clinicians and patients”, said Jonas Ehinger, CEO Osstell. “Being able to monitor osseointegration after place- ment will allow optimal implant treatment, including reduced treat- ment times and improved manage- ment of patients with risk factors.” Objective measurement of implant stability The integration of the proprie- tary Osstell ISQ (Implant Stability Quotient) technology in the new Im- plantmed device allows the user to benefit from non-invasive monitor- ing of osseointegration. Knowing the right time to load an implant is be- coming increasingly complex due to all the key parameters and risk fac- tors that need to be considered for each patient. The ISQ measurements allow clinicians working with implants to make decisions based on reliable and objective stability values when determining the course of treatment for each pa- tient. This procedure can be used to measure primary implant stability, observe osseointegration on the basis of sec- ondary stability readings and deter- mine the best possible time for load- ing the implant, thereby helping to prevent failures and ensuring high quality. The W&H Osstell ISQ module is available as an option and can also easily be retrofitted for use on one of the new generation of Implantmed devices. “While developing our product solutions, we constantly aim to set new benchmarks for the dental mar- ket. In this regard, we do not just fo- cus on the capabilities of our own company but also actively look for collaboration with suitable external partners. This approach has once again been impressively demon- strated by our development of the new generation of Implantmed and our successful partnership with Oss- tell,” commented W&H’s Managing Director Peter Malata.  Osstell, Sweden www.osstell.com Booth S18 W&H, Austria www.wh.com Booth S10 OSSTELL PARTNERS WITH W&H TO BRING INNOVATIVE AND INTEGRATED SOLUTION TO DENTAL IMPLANT PROCEDURES  Nobel Biocare’s Multi-unit Abutment Plus is a key enabler for the All-on-4 treatment concept. 25th 25th 25 EAO Annual Scientific Meeting th EAO Annual Scientific Meeting th 26 bility measurement, Osstell, just announced its partnership with the Austrian dental company W&H Dentalwerk . The collab- oration will focus on bring- ing innovative all-in-one solu- tions to support dental im- plant clinicians in their every- day practice. The first result of this partnership is now be- ing introduced in the form of W&H’s latest generation surgi- cal device, Implantmed, for which an integrated Osstell ISQ module is available. This unique combination of tech- nologies allows a new stand- ard to be set in the global den- prove patient confidence and com- fort and giving users significant benefits in terms of functional- ity and optimum efficiency during treatment. W&H is known in the global dental market as a leading manufacturer of den- tal precision instruments and devices. Innovative prowess and outstanding quality have been at the heart of the company for over 125 years, as have lasting collaborative partnerships. “We are very happy that such a recog- nised company like W&H has cho- sen to partner with Osstell, with the intent to bring innovative products to the market that will help clinicians to even further improve implant treatment and bility diagnostics combined with the state of the art Implantmed for the surgical placement, provides a unique opportunity benefitting both clinicians and patients”, said Jonas Ehinger, CEO Osstell. “Being able to monitor osseointegration after place- ment will allow optimal implant treatment, including reduced treat- ment times and improved manage- ment of patients with risk factors.” Objective measurement of implant stability The integration of the proprie- tary Osstell ISQ (Implant Stability Quotient) technology in the new Im- plantmed device allows the user to benefit from non-invasive monitor- ing of osseointegration. Knowing the right time to load an implant is be- coming increasingly complex due to all the key parameters and risk fac- tors that need to be considered for each patient. The ISQ measurements allow clinicians working with implants to make decisions based on reliable and objective stability values when determining the course  Peter Malata and Jonas Ehinger.‚∑

Seitenübersicht